Celldex Therapeutics, Inc. (CLDX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 26.24 |
| Open | 26.34 |
| Bid | 24.38 x 1100 |
| Ask | 26.86 x 1800 |
| Day's Range | 25.20 - 26.34 |
| 52 Week Range | 25.20 - 48.40 |
| Volume | |
| Avg. Volume | 424,180 |
| Market Cap | 1.203B |
| Beta (5Y Monthly) | 2.14 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
Celldex (CLDX) delivered earnings and revenue surprises of 0% and 60%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Celldex Therapeutics (NASDAQ:CLDX) Is In A Good Position To Deliver On Growth Plans
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- Zacks
Celldex Therapeutics (CLDX) Reports Q1 Loss, Tops Revenue Estimates
Celldex (CLDX) delivered earnings and revenue surprises of 1.59% and 157.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
